AdvanCell Enters Into Strategic Collaboration with Lilly to Advance Novel Targeted Alpha Therapies for the Treatment of CancerBusiness Wire • 02/10/25
OliX and Lilly Enter Global Licensing Agreement for MASH and Other Cardiometabolic IndicationsBusiness Wire • 02/10/25
Most patients on Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease achieved sustained clinical remission and endoscopic response at two yearsPRNewsWire • 02/07/25
Eli Lilly Q4 Earnings: Now The Magical $1 Trillion Dollar Market Cap Is In SightSeeking Alpha • 02/06/25
Compared to Estimates, Lilly (LLY) Q4 Earnings: A Look at Key MetricsZacks Investment Research • 02/06/25
LLY's Q4 Earnings Beat, Mounjaro, Zepbound Sales Fall Shy of EstimatesZacks Investment Research • 02/06/25
Why did Eli Lilly report mixed Q4 results despite soaring demand for Zepbound and Mounjaro?Invezz • 02/06/25
Eli Lilly Q4 Earnings: Strong Demand For Mounjaro But Prices Dip, Forecasts Over 30% Jump In 2025 Sales On Newer MedicinesBenzinga • 02/06/25
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expectedCNBC • 02/06/25